CINQAIR
Reslizumab
Listed by Teva Respiratory, LLC
- Strength
- 10 mg/mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- Interleukin-5 Antagonist
What it contains
- Reslizumab 10 mg/mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Interleukin-5 Antagonist |
| Approval route | BLA — biologic licence |
| NDC code | 59310-610 |
| FDA application | BLA761033 |
| RxNorm concept | 1746893 |
| Package sizes listed | 1 |
| Marketed since | April 2016 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.